A 12-month clinical investigation with a 24-day regimen containing 15 μg ethinylestradiol plus 60 μg gestodene with respect to hemostasis and cycle control
To access this article, please choose from the options below
PII: S0010-7824(01)00213-X
© 2001 Elsevier Science Inc. All rights reserved.
